• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human LisH domain-containing protein ARMC9 (ARMC9), Truncated

ACP15466

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15466 Target NameARMC9
Target SynonymsARMC9; KIAA1868LisH domain-containing protein ARMC9; Armadillo repeat-containing protein 9; Melanoma/melanocyte-specific tumor antigen KU-MEL-1; NS21FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ7Z3E5
Background Information
  • Uniprot Id

    Q7Z3E5

  • Target Species

    Human

  • Target Name

    ARMC9

  • Target Full Name

    LisH domain-containing protein ARMC9

  • Target Function

    Acts as a positive regulator of hedgehog (Hh)signaling. Involved in ciliogenesis. May participate in the trafficking and/or retention of GLI2 and GLI3 proteins at the ciliary tip.

  • Target Subcellular Location

    Cytoplasm, cytoskeleton, cilium basal body. Cell projection, cilium. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole.

  • Target Tissue Specificity

    Strongly expressed in most melanomas and melanocytes. Weakly expressed in the testis.

  • Target Synonyms

    ARMC9; KIAA1868LisH domain-containing protein ARMC9; Armadillo repeat-containing protein 9; Melanoma/melanocyte-specific tumor antigen KU-MEL-1; NS21

Inquire Recombinant Human LisH domain-containing protein ARMC9 (ARMC9), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification